TIAA Trust National Association Sells 1,577 Shares of GE HealthCare Technologies Inc. $GEHC

TIAA Trust National Association reduced its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 15.2% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 8,814 shares of the company’s stock after selling 1,577 shares during the quarter. TIAA Trust National Association’s holdings in GE HealthCare Technologies were worth $653,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also modified their holdings of the company. N.E.W. Advisory Services LLC bought a new stake in shares of GE HealthCare Technologies during the first quarter valued at approximately $25,000. Bogart Wealth LLC raised its position in shares of GE HealthCare Technologies by 260.0% during the first quarter. Bogart Wealth LLC now owns 342 shares of the company’s stock valued at $28,000 after buying an additional 247 shares during the last quarter. Gladwyn Financial Advisors Inc. bought a new stake in shares of GE HealthCare Technologies during the second quarter valued at approximately $34,000. Game Plan Financial Advisors LLC raised its position in shares of GE HealthCare Technologies by 295.3% during the second quarter. Game Plan Financial Advisors LLC now owns 502 shares of the company’s stock valued at $37,000 after buying an additional 375 shares during the last quarter. Finally, Zions Bancorporation National Association UT bought a new stake in shares of GE HealthCare Technologies during the first quarter valued at approximately $42,000. 82.06% of the stock is currently owned by institutional investors.

GE HealthCare Technologies Trading Down 0.2%

GEHC stock opened at $74.30 on Wednesday. The firm has a fifty day moving average price of $75.10 and a 200 day moving average price of $73.31. GE HealthCare Technologies Inc. has a fifty-two week low of $57.65 and a fifty-two week high of $94.80. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.95 and a current ratio of 1.18. The firm has a market cap of $33.85 billion, a PE ratio of 15.35, a price-to-earnings-growth ratio of 2.80 and a beta of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share for the quarter, beating analysts’ consensus estimates of $1.05 by $0.02. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. The firm had revenue of $5.14 billion during the quarter, compared to analyst estimates of $5.07 billion. During the same period last year, the firm posted $1.14 earnings per share. GE HealthCare Technologies’s revenue for the quarter was up 5.8% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. Sell-side analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 24th will be paid a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date of this dividend is Friday, October 24th. GE HealthCare Technologies’s payout ratio is presently 2.89%.

Analysts Set New Price Targets

Several research firms have recently issued reports on GEHC. Citigroup cut shares of GE HealthCare Technologies from a “buy” rating to a “neutral” rating and reduced their price objective for the company from $93.00 to $83.00 in a research report on Tuesday, October 7th. Weiss Ratings reiterated a “hold (c+)” rating on shares of GE HealthCare Technologies in a research report on Tuesday, October 14th. Morgan Stanley lifted their price objective on shares of GE HealthCare Technologies from $74.00 to $80.00 and gave the company an “equal weight” rating in a research report on Thursday, October 30th. BTIG Research set a $87.00 price objective on shares of GE HealthCare Technologies in a research report on Wednesday, October 29th. Finally, Zacks Research lowered shares of GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a report on Monday, September 29th. Six investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $86.10.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.